NCT05128890 Evaluation of Resection Techniques for Pancreatic Tumors
| NCT ID | NCT05128890 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Methodist Health System |
| Condition | Surgery |
| Study Type | OBSERVATIONAL |
| Enrollment | 431 participants |
| Start Date | 2016-04-16 |
| Primary Completion | 2027-04-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 431 participants in total. It began in 2016-04-16 with a primary completion date of 2027-04-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint. The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Eligibility Criteria
Inclusion Criteria: * Patients that have undergone pancreatic or liver resection surgeries from January 2006 until December 2020 at Methodist Dallas Medical Center (MDMC) * Patients 18 years old or older Exclusion Criteria: * Patients that have not undergone pancreatic resection surgeries * Patients under 18 years of age
Contact & Investigator
Alejandro Mejia, M.D.
PRINCIPAL INVESTIGATOR
The Liver Institute, Methodist Dallas Medical Center
Frequently Asked Questions
Who can join the NCT05128890 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05128890 currently recruiting?
Yes, NCT05128890 is actively recruiting participants. Contact the research team at ClinicalResearch@mhd.com for enrollment information.
Where is the NCT05128890 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT05128890 clinical trial?
NCT05128890 is sponsored by Methodist Health System. The principal investigator is Alejandro Mejia, M.D. at The Liver Institute, Methodist Dallas Medical Center. The trial plans to enroll 431 participants.